Relationship Between Symptoms, Retinal Morphology, and the Nigrostriatal Dopamine System in Parkinson's Disease

NCT02443779 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7

Last updated 2019-04-12

No results posted yet for this study

Summary

The purpose of this study is to examine if a correlation exists between findings from brain imaging studies of the status of the dopamine system in the brain using DaTscan and SPECT imaging, clinical symptoms of Parkinson's disease, and changes in the structure of the retina as detected by optical coherence tomography (OCT) in recently diagnosed and more advanced Parkinson's disease patients.

Conditions

Sponsors & Collaborators

  • Wills Eye Hospital

    collaborator UNKNOWN
  • Thomas Jefferson University

    lead OTHER

Principal Investigators

  • Jay S Schneider, PhD · Thomas Jefferson University

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2018-07-31
Completion
2018-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02443779 on ClinicalTrials.gov